SCHEMBL745454

SCHEMBL745454

CS(=O)(=O)N1CCC2(CCN(c3ccc(OC(F)(F)F)cc3)C2)CC1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 7/20 0.54
CYP2D6 P10635 4/20 0.54
HIF1A Q16665 2/20 0.54
CYP2C9 P11712 8/20 0.54
CYP2C19 P33261 7/20 0.54
MAPK1 P28482 2/20 0.54
USP2 O75604 6/20 0.53
HSD17B10 Q99714 6/20 0.53
SMN1; SMN2 Q16637 3/20 0.53
MEN1 O00255 1/20 0.53
KMT2A Q03164 1/20 0.53
TSHR P16473 2/20 0.50
CYP3A4 P08684 5/20 0.49
ALDH1A1 P00352 5/20 0.49
RECQL P46063 1/20 0.46
HPGD P15428 5/20 0.45
EPHX2 P34913 2/20 0.45
LIPE Q05469 2/20 0.43
ALOX15 P16050 1/20 0.43
PTGS2 P35354 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26552871 0.83 ALDH1A1 (0.47) ALDH1A1EPHX2
SCHEMBL745746 0.82 CYP3A4 (0.58) CYP1A2CYP2D6HIF1ACYP2C9CYP2C19
SCHEMBL744430 0.81 LIPE (0.68) CYP1A2CYP2D6CYP2C9CYP2C19USP2
SCHEMBL746527 0.80 LIPE (0.43) EPHX2LIPE
SCHEMBL5019 0.80 SLC6A4 (0.49) EPHX2LIPE
SCHEMBL746672 0.78 CYP3A4 (0.73) CYP1A2CYP2D6HIF1ACYP2C9CYP2C19
SCHEMBL743295 0.78 LIPE (0.43) CYP1A2CYP2D6CYP2C9CYP2C19TSHR
SCHEMBL764042 0.78 CYP3A4 (0.52) CYP1A2CYP2D6HIF1ACYP2C9CYP2C19
SCHEMBL24227415 0.78 USP2 (0.46) CYP1A2CYP2D6CYP2C19MAPK1USP2
SCHEMBL5888 0.77 EPHX2 (0.49) EPHX2LIPE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2430023-A1 AZACYCLIC SPIRODERIVATIVES AS HSL INHIBITORS F. Hoffmann-La Roche AG (CH) 2012-03-21 EP disclosed
WO-2010130665-A1 AZACYCLIC SPIRODERIVATIVES AS HSL INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2010-11-18 WO disclosed